查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1985087

2026年病理切片品管人工智慧（AI）全球市场报告

Pathology Slide Quality Control Artificial Intelligence (AI) Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，用于病理切片品管的人工智慧市场发展迅速。预计该市场规模将从2025年的5.3亿美元成长到2026年的6.4亿美元，复合年增长率达21.3%。成长要素包括：数位病理学的日益普及、对更精准诊断的需求不断增长、工作流程自动化需求增加、检查室基础设施的改善以及对品质保证的日益重视。

预计未来几年，用于病理切片品管的人工智慧市场将大幅成长，到2030年将达到13.8亿美元，复合年增长率（CAGR）为21.0%。预测期内的成长预计将受到以下因素的推动：人工智慧（AI）在病理学领域的应用日益广泛、对基于AI的品管投资不断增加、数位病理学监管支持力度加大、云端病理平台的扩展以及远端病理解决方案的日益普及。预测期内的关键趋势包括：切片扫描技术的进步、基于AI的影像分析技术的创新、组织品质评估自动化技术的进步、伪影检测技术的研究与开发以及染色和切片品质评估技术的进步。

预计未来几年，诊断测试数量的不断增长将推动病理切片品管人工智慧市场的发展。诊断测试数量的增长指的是为检测疾病而进行的医学检测和组织分析数量的增加，这主要是由于人口老化和筛检计画的扩展所致。数位病理学的进步正在为管理日益增长的检测量提供支持，因为在高通量环境下，需要自动化工具来保持准确性和效率。病理切片品管人工智慧透过使用机器学习演算法，在病理学家审核之前自动检测数位切片影像中的错误、伪影和异常，从而改善诊断工作流程。例如，根据英国国家医疗服务体系（NHS England，英国的公共医疗保健系统）的数据，2024/25年度平均每月进行240万次诊断测试，上年度去年同期成长8%。因此，诊断测试的扩展正在推动病理切片品管人工智慧市场的成长。

病理切片品管人工智慧市场的主要企业正致力于技术进步，包括将人工智慧驱动的自动化品管解决方案整合到数位病理工作流程中。这些解决方案利用深度学习演算法，在病理学家审查之前自动检测并标记所有切片影像中的伪影、失焦区域和其他品质问题，从而减少人工操作，最大限度地减少诊断错误，并确保为后续分析提供高品质的输入。例如，2023年3月，专注于人工智慧病理解决方案的荷兰医疗软体公司Aiosyn BV发布了AiosynQC，这是一个由人工智慧驱动的自动化品管平台。这款模组化软体可与现有的数位病理系统配合使用，识别并突出显示苏木精-伊红（H&E）染色切片影像中的失焦区域和其他伪影，从而支持实验室和诊断实验室更高效、更准确的品质审核流程。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球病理切片品管人工智慧（AI）市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 生物技术、基因组学和精准医疗
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施、互联生态系统
  • 主要趋势
    • 扩展自动化载玻片品质评估
    • 基于人工智慧的影像分析工具的整合正在逐步推进。
    • 扩大诊断前品管软体的使用
    • 扩展以工作流程为中心的品管系统
    • 我们将更加重视诊断的准确性和一致性。

第五章 终端用户产业市场分析

  • 医院
  • 诊断检查室
  • 研究机构
  • 大学医院
  • 参考病理检查室

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球病理切片品管人工智慧（AI）市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球病理切片品管人工智慧（AI）市场规模、对比及成长率分析
  • 全球病理切片品管人工智慧（AI）市场表现：规模与成长，2020-2025年
  • 全球病理切片品管人工智慧（AI）市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 按组件
  • 软体、硬体和服务
  • 部署模式
  • 本机部署、云端部署
  • 透过使用
  • 品质保证工具（专用品管）、分析前品管、分析中品管、分析后品管、工作流程管理
  • 最终用户
  • 医院、诊断检查室、研究机构、学术机构和其他最终用户
  • 按类型细分：软体
  • 影像分析演算法、切片品质评估工具、工作流程管理系统、资料整合平台、云端部署平台
  • 按类型细分：硬体
  • 数位幻灯片扫描器、成像工作站、高解析度相机系统、计算单元、资料储存伺服器
  • 按类型细分：服务
  • 安装服务、系统整合服务、技术支援服务、培训和教育服务、维护和升级服务

第十章 区域与国别分析

  • 全球病理切片品管人工智慧（AI）市场：按地区划分，历史资料及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球病理切片品管人工智慧（AI）市场：按国家划分，实际值和预测值，2020-2025年、2025-2030年预测值、2035年预测值

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 人工智慧（AI）在病理切片品管领域的市场：竞争格局和市场份额（2024年）
  • 病理切片品管人工智慧（AI）市场：公司估值矩阵
  • 病理切片品管人工智慧（AI）市场：公司概况
    • F. Hoffmann-La Roche Ltd.
    • Philips Healthcare
    • Leica Biosystems GmbH
    • XIFIN Inc.
    • Stratipath Inc.

第37章 其他大型企业和创新企业

  • PathAI Inc., Owkin Inc., Lunit Inc., Paige.AI Inc., Proscia Inc., Visiopharm A/S, Indica Labs Inc., Inspirata Inc., PreciseDx Inc., Aiforia Technologies Oyj, Ibex Medical Analytics Ltd., Deep Bio Inc., Nucleai Ltd., AIRA Matrix Inc., HistoIndex Pte Ltd.

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：具有高市场潜力的国家、细分市场与策略

  • 2030年病理切片品管人工智慧（AI）市场：提供新机会的国家
  • 病理切片品管人工智慧（AI）市场2030：提供新机会的细分市场
  • 2030年病理切片品管人工智慧（AI）市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: HS4MPSQC01_G26Q1

Pathology slide quality control artificial intelligence refers to software systems that leverage advanced algorithms and machine learning techniques to automatically assess digital pathology slides for issues such as focus errors, staining variability, artifacts, and tissue coverage prior to diagnostic review. These systems are used to maintain consistent slide quality, reduce manual review workload, prevent diagnostic delays, and enhance accuracy and efficiency in pathology workflows.

The primary components of pathology slide quality control artificial intelligence (AI) include software, hardware, and services. Software refers to AI-driven platforms designed to automate evaluation of pathology slides, detect errors, and ensure consistent quality across pre-analytic, analytic, and post-analytic processes. Different deployment modes include on-premises and cloud-based. Multiple applications cover quality assurance tools (dedicated quality control), pre-analytic quality control, analytic quality control, post-analytic quality control, and workflow management, and they are used by several end users comprising hospitals, diagnostic laboratories, research institutes, academic centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the pathology slide quality control artificial intelligence market by increasing costs of imported digital slide scanners, high-performance computing hardware, imaging sensors, and data storage systems required for ai-driven pathology workflows. hospitals and diagnostic laboratories in north america and europe are most affected due to reliance on advanced imported hardware, while asia-pacific faces cost pressures on scanner manufacturing and deployment. these tariffs are increasing upfront capital expenditure and slowing procurement cycles for smaller laboratories. however, they are also encouraging localized hardware assembly, regional software development, and greater adoption of cloud-based quality control solutions that reduce dependency on imported infrastructure.

The pathology slide quality control artificial intelligence (AI) market research report is one of a series of new reports from The Business Research Company that provides pathology slide quality control artificial intelligence (AI) market statistics, including pathology slide quality control artificial intelligence (AI) industry global market size, regional shares, competitors with a pathology slide quality control artificial intelligence (AI) market share, detailed pathology slide quality control artificial intelligence (AI) market segments, market trends and opportunities, and any further data you may need to thrive in the pathology slide quality control artificial intelligence (AI) industry. This pathology slide quality control artificial intelligence (AI) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pathology slide quality control artificial intelligence market size has grown exponentially in recent years. It will grow from $0.53 billion in 2025 to $0.64 billion in 2026 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to increasing adoption of digital pathology, growing need for accurate diagnostics, rising demand for workflow automation, expansion of laboratory infrastructure, and increasing focus on quality assurance.

The pathology slide quality control artificial intelligence market size is expected to see exponential growth in the next few years. It will grow to $1.38 billion in 2030 at a compound annual growth rate (CAGR) of 21.0%. The growth in the forecast period can be attributed to growing integration of artificial intelligence in pathology, rising investments in artificial intelligence (AI)-based quality control, increasing regulatory support for digital pathology, expansion of cloud-based pathology platforms, and growing adoption of telepathology solutions. Major trends in the forecast period include technology advancements in slide scanning, innovations in artificial intelligence (AI)-based image analysis, developments in automated tissue quality assessment, research and developments in artifact detection, and advancements in stain and section quality evaluation.

The rising volume of diagnostic testing is expected to drive the growth of the pathology slide quality control artificial intelligence (AI) market in the coming years. Increasing diagnostic volumes refer to the growing number of medical tests and tissue analyses conducted to detect diseases, fueled by aging populations and expanded screening programs. Advancements in digital pathology support the management of these growing volumes, as automated tools are required to maintain accuracy and efficiency in high-throughput environments. Pathology slide quality control AI enhances diagnostic workflows by using machine learning algorithms to automatically detect errors, artifacts, and anomalies in digital slide images before pathologist review. For example, according to NHS England, the UK-based publicly funded healthcare system, an average of 2.4 million diagnostic tests were conducted per month during 2024/25, marking an 8% increase from the previous year. Consequently, the expansion of diagnostic testing volumes is propelling the growth of the pathology slide quality control AI market.

Major companies in the pathology slide quality control artificial intelligence (AI) market are focusing on technological advancements, such as introducing AI-powered automated quality control solutions integrated into digital pathology workflows. These solutions use deep learning algorithms to automatically detect and flag artifacts, out-of-focus areas, and other quality issues in whole-slide images before pathologist review, reducing manual workload, minimizing diagnostic errors, and ensuring high-quality inputs for subsequent analysis. For example, in March 2023, Aiosyn B.V., a Netherlands-based medical software company specializing in AI-powered pathology solutions, launched AiosynQC, an AI-driven automated quality control platform. This modular software integrates with existing digital pathology systems to identify and highlight out-of-focus regions and other artifacts in hematoxylin and eosin (H&E) stained slide images, supporting a more efficient and accurate quality review process for research and diagnostic laboratories.

In August 2025, Tempus AI Inc., a US-based technology company specializing in artificial intelligence for precision medicine, acquired Paige for approximately $81.25 million. Through this acquisition, Tempus AI Inc. aimed to expand its digital pathology portfolio and reinforce its position in AI-driven precision medicine by incorporating Paige's extensive dataset of millions of digitized pathology slides and advanced AI applications into its multimodal data library. Paige is a US-based AI company focused on digital pathology solutions and clinical AI applications for cancer diagnosis and treatment planning.

Major companies operating in the pathology slide quality control artificial intelligence (AI) market are F. Hoffmann-La Roche Ltd., Philips Healthcare, Leica Biosystems GmbH, XIFIN Inc., Stratipath Inc., PathAI Inc., Owkin Inc., Lunit Inc., Paige.AI Inc., Proscia Inc., Visiopharm A/S, Indica Labs Inc., Inspirata Inc., PreciseDx Inc., Aiforia Technologies Oyj, Ibex Medical Analytics Ltd., Deep Bio Inc., Nucleai Ltd., AIRA Matrix Inc., HistoIndex Pte Ltd., Techcyte Inc.

North America was the largest region in the pathology slide quality control artificial intelligence market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pathology slide quality control artificial intelligence (AI) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pathology slide quality control artificial intelligence (AI) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pathology slide quality control artificial intelligence market consists of revenues earned by entities by providing services such as automated slide quality assessment, focus and blur detection, staining consistency evaluation, artifact identification, and pre-diagnostic slide validation. The market value includes the value of related goods sold by the service provider or included within the service offering. The pathology slide quality control artificial intelligence market also includes sales of artificial intelligence-powered quality control software, digital pathology analysis platforms, slide assessment algorithms, workflow integration tools, and quality reporting modules. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pathology Slide Quality Control Artificial Intelligence (AI) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pathology slide quality control artificial intelligence (ai) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pathology slide quality control artificial intelligence (ai) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pathology slide quality control artificial intelligence (ai) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Deployment Mode: On-Premises; Cloud-Based
  • 3) By Application: Quality Assurance Tools (Dedicated Quality Control); Pre-Analytic Quality Control; Analytic Quality Control; Post-Analytic Quality Control; Workflow Management
  • 4) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Academic Centers; Other End Users
  • Subsegments:
  • 1) By Software: Image Analysis Algorithms; Slide Quality Scoring Tools; Workflow Management Systems; Data Integration Platforms; Cloud Deployment Platforms
  • 2) By Hardware: Digital Slide Scanners; Imaging Workstations; High Resolution Camera Systems; Computational Processing Units; Data Storage Servers
  • 3) By Services: Installation Services; System Integration Services; Technical Support Services; Training And Education Services; Maintenance And Upgradation Services
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Philips Healthcare; Leica Biosystems GmbH; XIFIN Inc.; Stratipath Inc.; PathAI Inc.; Owkin Inc.; Lunit Inc.; Paige.AI Inc.; Proscia Inc.; Visiopharm A/S; Indica Labs Inc.; Inspirata Inc.; PreciseDx Inc.; Aiforia Technologies Oyj; Ibex Medical Analytics Ltd.; Deep Bio Inc.; Nucleai Ltd.; AIRA Matrix Inc.; HistoIndex Pte Ltd.; Techcyte Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Pathology Slide Quality Control Artificial Intelligence (AI) Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Pathology Slide Quality Control Artificial Intelligence (AI) Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Pathology Slide Quality Control Artificial Intelligence (AI) Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Pathology Slide Quality Control Artificial Intelligence (AI) Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Biotechnology, Genomics & Precision Medicine
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Automated Slide Quality Assessment
    • 4.2.2 Rising Integration Of Ai-Based Image Analysis Tools
    • 4.2.3 Growing Use Of Pre-Diagnostic Quality Control Software
    • 4.2.4 Expansion Of Workflow-Centric Quality Management Systems
    • 4.2.5 Enhanced Focus On Diagnostic Accuracy And Consistency

5. Pathology Slide Quality Control Artificial Intelligence (AI) Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Research Institutes
  • 5.4 Academic Medical Centers
  • 5.5 Reference Pathology Labs

6. Pathology Slide Quality Control Artificial Intelligence (AI) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pathology Slide Quality Control Artificial Intelligence (AI) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Pathology Slide Quality Control Artificial Intelligence (AI) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Pathology Slide Quality Control Artificial Intelligence (AI) Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Pathology Slide Quality Control Artificial Intelligence (AI) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Pathology Slide Quality Control Artificial Intelligence (AI) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pathology Slide Quality Control Artificial Intelligence (AI) Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pathology Slide Quality Control Artificial Intelligence (AI) Market Segmentation

  • 9.1. Global Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software, Hardware, Services
  • 9.2. Global Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • On-Premises, Cloud-Based
  • 9.3. Global Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Quality Assurance Tools (Dedicated Quality Control), Pre-Analytic Quality Control, Analytic Quality Control, Post-Analytic Quality Control, Workflow Management
  • 9.4. Global Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Laboratories, Research Institutes, Academic Centers, Other End Users
  • 9.5. Global Pathology Slide Quality Control Artificial Intelligence (AI) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Image Analysis Algorithms, Slide Quality Scoring Tools, Workflow Management Systems, Data Integration Platforms, Cloud Deployment Platforms
  • 9.6. Global Pathology Slide Quality Control Artificial Intelligence (AI) Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Digital Slide Scanners, Imaging Workstations, High Resolution Camera Systems, Computational Processing Units, Data Storage Servers
  • 9.7. Global Pathology Slide Quality Control Artificial Intelligence (AI) Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Installation Services, System Integration Services, Technical Support Services, Training And Education Services, Maintenance And Upgradation Services

10. Pathology Slide Quality Control Artificial Intelligence (AI) Market Regional And Country Analysis

  • 10.1. Global Pathology Slide Quality Control Artificial Intelligence (AI) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Pathology Slide Quality Control Artificial Intelligence (AI) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 11.1. Asia-Pacific Pathology Slide Quality Control Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 12.1. China Pathology Slide Quality Control Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 13.1. India Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 14.1. Japan Pathology Slide Quality Control Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 15.1. Australia Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 16.1. Indonesia Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 17.1. South Korea Pathology Slide Quality Control Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 18.1. Taiwan Pathology Slide Quality Control Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 19.1. South East Asia Pathology Slide Quality Control Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 20.1. Western Europe Pathology Slide Quality Control Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 21.1. UK Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 22.1. Germany Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 23.1. France Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 24.1. Italy Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 25.1. Spain Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 26.1. Eastern Europe Pathology Slide Quality Control Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 27.1. Russia Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 28.1. North America Pathology Slide Quality Control Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 29.1. USA Pathology Slide Quality Control Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 30.1. Canada Pathology Slide Quality Control Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 31.1. South America Pathology Slide Quality Control Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 32.1. Brazil Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 33.1. Middle East Pathology Slide Quality Control Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pathology Slide Quality Control Artificial Intelligence (AI) Market

  • 34.1. Africa Pathology Slide Quality Control Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Pathology Slide Quality Control Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pathology Slide Quality Control Artificial Intelligence (AI) Market Regulatory and Investment Landscape

36. Pathology Slide Quality Control Artificial Intelligence (AI) Market Competitive Landscape And Company Profiles

  • 36.1. Pathology Slide Quality Control Artificial Intelligence (AI) Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Pathology Slide Quality Control Artificial Intelligence (AI) Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Pathology Slide Quality Control Artificial Intelligence (AI) Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Leica Biosystems GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. XIFIN Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Stratipath Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Pathology Slide Quality Control Artificial Intelligence (AI) Market Other Major And Innovative Companies

  • PathAI Inc., Owkin Inc., Lunit Inc., Paige.AI Inc., Proscia Inc., Visiopharm A/S, Indica Labs Inc., Inspirata Inc., PreciseDx Inc., Aiforia Technologies Oyj, Ibex Medical Analytics Ltd., Deep Bio Inc., Nucleai Ltd., AIRA Matrix Inc., HistoIndex Pte Ltd.

38. Global Pathology Slide Quality Control Artificial Intelligence (AI) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pathology Slide Quality Control Artificial Intelligence (AI) Market

40. Pathology Slide Quality Control Artificial Intelligence (AI) Market High Potential Countries, Segments and Strategies

  • 40.1 Pathology Slide Quality Control Artificial Intelligence (AI) Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Pathology Slide Quality Control Artificial Intelligence (AI) Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Pathology Slide Quality Control Artificial Intelligence (AI) Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer